Related Experiment Videos

Treatment Patterns And Outcomes Of Patients Diagnosed With Ovarian Cancer In The Netherlands: A Registry Study

E Houben¹, H G M van Haalen², W Sparreboom²

¹PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research

|May 21, 2016

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

GP Consultations for Venous Thromboembolism (VTE) After mRNA and Adeno-Vector-Based COVID-19 Vaccination-An Exposure-Anchored Self-Controlled Cohort Study Based on Primary Healthcare Data From the Netherlands.

Pharmacoepidemiology and drug safety·2026

Type 2 diabetes monitoring and control in migrants and non-migrants: A population-based cohort study in primary care in the Netherlands.

Primary care diabetes·2025

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial.

Breast (Edinburgh, Scotland)·2023

Cohort profile: the PHARMO Perinatal Research Network (PPRN) in the Netherlands: a population-based mother-child linked cohort.

BMJ open·2020

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

Trends in mortality, cardiovascular complications, and risk factors in type 2 diabetes.

The Netherlands journal of medicine·2019

See all related articles